Insmed Incorporated (LON:0JAV)
162.56
-2.70 (-1.63%)
At close: Oct 14, 2025
Insmed Revenue
Insmed had revenue of $107.42M USD in the quarter ending June 30, 2025, with 18.90% growth. This brings the company's revenue in the last twelve months to $398.11M, up 21.15% year-over-year. In the year 2024, Insmed had annual revenue of $363.71M with 19.17% growth.
Revenue (ttm)
$398.11M
Revenue Growth
+21.15%
P/S Ratio
88.81
Revenue / Employee
$313.22K
Employees
1,271
Market Cap
25.81B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 363.71M | 58.50M | 19.17% |
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Insmed News
- 4 weeks ago - INSM Quantitative Stock Analysis - Benjamin Graham - Nasdaq
- 5 weeks ago - JPMorgan Chase & Co. Expands Holdings in Insmed Inc. with Significant Share Acquisition - GuruFocus
- 5 weeks ago - Insmed Incorporated (INSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Guggenheim Raises Insmed (INSM) Price Target to $172 | INSM Stock News - GuruFocus
- 5 weeks ago - 3 Stocks To Consider After Google's Favorable Anti-Trust Ruling - Benzinga
- 5 weeks ago - Insmed Incorporated (INSM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Insmed Reports Inducement Grants Under Nasdaq Rule | INSM stock news - GuruFocus
- 5 weeks ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire